Hosted on MSN
Big Pharma has a Trump problem
President Donald Trump's clamp-down on federal science funding has handed Big Pharma an existential headache: the National Institutes of Health (NIH) has terminated more than 2,100 research grants and ...
Add Yahoo as a preferred source to see more of our stories on Google. Illustration: Trump vs pharma A string of pharmaceutical bosses attended a three-hour dinner at Donald Trump’s Mar-a-Lago resort ...
There’s probably no industry more reviled in the age of populism than Big Pharma. Both political parties now engage in knee-jerk demonization of one of the most successful and valuable sectors of the ...
Protecting the rights of Americans is my top priority. I believe in the power of the free-market and the importance of limited government overreach. However, today our health care system is under ...
Pharmacy benefit managers, or PBMs, are crucial in helping employers like me negotiate with drug manufacturers, secure rebates, and pass down savings to keep costs manageable for businesses and ...
Big Pharma recently announced a marketing campaign posing as patient advocacy. The industry’s trade association and advocacy arm said it is spending hundreds of billions of dollars to develop drugs ...
Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...
Still life of Ozempic and Wegovy. Both are injectable prescription weight loss medicines. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) As demand surges for semaglutide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results